Design Therapeutics plans to raise up to $240M in IPO
March 23, 2021
Biotech company Design Therapeutics has set terms to raise as much as $240 million in its IPO. The company plans to sell 12 million shares for between $18 and $20 each in the offering. Design's top shareholders include SR One (10% post-IPO stake), Quan Funds (8.8%) and Cormorant (8.1%).